PBYA

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 12/29/2016
Contact Info
  • 1517 San Jacinto Street
  • Houston, TX 77002

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jan 31, 2017 10-Q
CIK 0001530981
Fiscal Year End 10/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8700 - Services-Engineering, Accounting, Research, Management
Incorporated In: NV, USA
Year of Inc. 2011
Employees 15 a/o Jan 31, 2017
Company Officers/Contacts
Evan Mark Levine CEO
Noah Isadore Davis COO
Steven M. Plumb, CPA CFO
Company Directors
Evan Mark Levine Chairman
Steven M. Plumb, CPA
Noah Isadore Davis
Service Providers
Accounting/Auditing Firm
LBB & Associates Ltd., LLP
10260 Westheimer Road
Suite 310
Houston, TX, 77042
United States
 
Securities Counsel
The Loev Law Firm, PC
6300 West Loop South
Suite 280
Bellaire, TX, 77401
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Panther Biotechnology, Inc. until 2-2017
  • Formerly=NEF Enterprises Inc until 6-2014
PBYA Security Details
Share Structure
Market Value1 $23,234,852 a/o Mar 22, 2017
Authorized Shares 100,000,000 a/o Aug 31, 2013
Outstanding Shares 44,627,482 a/o Feb 28, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 578,733 a/o Dec 02, 2016
Par Value 0.001
Transfer Agent(s) Verified by Transfer Agent
Signature Stock Transfer, Inc.
Shareholders
Shareholders of Record 96 a/o Mar 01, 2017
Short Selling Data
Short Interest 0 (-100%)
Jan 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security